Baird Financial »

Vir Biotechnology shares owned by Baird Financial

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Baird Financial from 13F filings

Historical chart of Baird Financial investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Baird Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Baird Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $103k 10k 10.06

More positions owned by Baird Financial

Microsoft Corp Common (MSFT)
Apple Computer Common (AAPL)
J.p. Morgan Chase Common (JPM)
Alphabet Common (GOOG)
Home Depot Common (HD)
Berkshire Hathaway Inc Del Cl Common (BRK.B)
Vanguard Tax-managed Fd Europe Common (VEA)
Ishares 1000 Growth Russell Common (IWF)
Johnson Johnson Common (JNJ)
Ishares 1000 Value Russell Common (IWD)
Ishares Midcap Russell Common (IWR)
Progressive Corp Ohio Common (PGR)
Fastenal Common (FAST)
Union Pacific Corp Common (UNP)
Costco Whsl Corp Common (COST)

View all positions for Baird Financial

Top funds holding Vir Biotechnology

Vanguard Group
Baillie Gifford & Co
Citadel Advisors
Alliancebernstein
Bill & Melinda Gates Foundation
Bank of New York Mellon
D. E. Shaw & Co
Charles Schwab Investment Management
Goldman Sachs Group
Voloridge Investment Management
UBS Group
Dimensional Fund Advisors
Principal Financial Group
Barclays
Millennium Management

View all funds holding Vir Biotechnology